Efficacy and safety of sofosbuvir–velpatasvir with or without ribavirin in HCV-infected Japanese patients with decompensated cirrhosis: an open-label phase 3 trial
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1435-5922
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Efficacy and safety of sofosbuvir–velpatasvir with or without ribavirin in HCV-infected Japanese patients with decompensated cirrhosis: an open-label phase 3 trial ; day:10 ; month:9 ; year:2018 ; pages:1-9
Journal of gastroenterology ; (10.9.2018), 1-9
- Creator
-
Takehara, Tetsuo
- Contributor
-
Sakamoto, Naoya
Nishiguchi, Shuhei
Ikeda, Fusao
Tatsumi, Tomohide
Ueno, Yoshiyuki
Yatsuhashi, Hiroshi
Takikawa, Yasuhiro
Kanda, Tatsuo
Sakamoto, Minoru
Tamori, Akihiro
Mita, Eiji
Chayama, Kazuaki
Zhang, Gulan
De-Oertel, Shampa
Dvory-Sobol, Hadas
Matsuda, Takuma
Stamm, Luisa M.
Brainard, Diana M.
Tanaka, Yasuhito
Kurosaki, Masayuki
SpringerLink (Online service)
- DOI
-
10.1007/s00535-018-1503-x
- URN
-
urn:nbn:de:101:1-2018102800141143087432
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Takehara, Tetsuo
- Sakamoto, Naoya
- Nishiguchi, Shuhei
- Ikeda, Fusao
- Tatsumi, Tomohide
- Ueno, Yoshiyuki
- Yatsuhashi, Hiroshi
- Takikawa, Yasuhiro
- Kanda, Tatsuo
- Sakamoto, Minoru
- Tamori, Akihiro
- Mita, Eiji
- Chayama, Kazuaki
- Zhang, Gulan
- De-Oertel, Shampa
- Dvory-Sobol, Hadas
- Matsuda, Takuma
- Stamm, Luisa M.
- Brainard, Diana M.
- Tanaka, Yasuhito
- Kurosaki, Masayuki
- SpringerLink (Online service)
Other Objects (12)
Successful Treatment with Crushed Sofosbuvir/Velpatasvir of a Patient with Decompensated Cirrhosis C and Thrombocytopenia
Outcomes after sofosbuvir-containing regimens for hepatitis C virus in patients with decompensated cirrhosis: a real-world study
Biomarkers of hepatocellular synthesis in patients with decompensated cirrhosis
Biomarkers of hepatocellular synthesis in patients with decompensated cirrhosis
Biomarkers of hepatocellular synthesis in patients with decompensated cirrhosis
Estimating the cost-effectiveness of daclatasvir + sofosbuvir versus sofosbuvir + ribavirin for patients with genotype 3 hepatitis C virus
Short-term hepatocyte function and portal hypertension outcomes of sofosbuvir/velpatasvir for decompensated hepatitis C-related cirrhosis
Risk factors and prognostic impact of new decompensated events in hospitalized patients with decompensated cirrhosis
Invasive pulmonary aspergillosis in patients with decompensated cirrhosis: case series
Discharge Outcomes of Hospitalized Patients with New Onset Decompensated Cirrhosis
Dynamic evolution of the sofosbuvir-associated variant A1343V in HEV-infected patients under concomitant sofosbuvir-ribavirin treatment
Decreased platelet aggregation in patients with decompensated liver cirrhosis and TIPS implantation
Successful Treatment with Crushed Sofosbuvir/Velpatasvir of a Patient with Decompensated Cirrhosis C and Thrombocytopenia
Outcomes after sofosbuvir-containing regimens for hepatitis C virus in patients with decompensated cirrhosis: a real-world study
Biomarkers of hepatocellular synthesis in patients with decompensated cirrhosis
Biomarkers of hepatocellular synthesis in patients with decompensated cirrhosis
Biomarkers of hepatocellular synthesis in patients with decompensated cirrhosis
Estimating the cost-effectiveness of daclatasvir + sofosbuvir versus sofosbuvir + ribavirin for patients with genotype 3 hepatitis C virus
Short-term hepatocyte function and portal hypertension outcomes of sofosbuvir/velpatasvir for decompensated hepatitis C-related cirrhosis
Risk factors and prognostic impact of new decompensated events in hospitalized patients with decompensated cirrhosis
Invasive pulmonary aspergillosis in patients with decompensated cirrhosis: case series
Discharge Outcomes of Hospitalized Patients with New Onset Decompensated Cirrhosis
Dynamic evolution of the sofosbuvir-associated variant A1343V in HEV-infected patients under concomitant sofosbuvir-ribavirin treatment
Decreased platelet aggregation in patients with decompensated liver cirrhosis and TIPS implantation
Successful Treatment with Crushed Sofosbuvir/Velpatasvir of a Patient with Decompensated Cirrhosis C and Thrombocytopenia
Outcomes after sofosbuvir-containing regimens for hepatitis C virus in patients with decompensated cirrhosis: a real-world study
Biomarkers of hepatocellular synthesis in patients with decompensated cirrhosis
Biomarkers of hepatocellular synthesis in patients with decompensated cirrhosis
Biomarkers of hepatocellular synthesis in patients with decompensated cirrhosis
Estimating the cost-effectiveness of daclatasvir + sofosbuvir versus sofosbuvir + ribavirin for patients with genotype 3 hepatitis C virus
Short-term hepatocyte function and portal hypertension outcomes of sofosbuvir/velpatasvir for decompensated hepatitis C-related cirrhosis
Risk factors and prognostic impact of new decompensated events in hospitalized patients with decompensated cirrhosis
Invasive pulmonary aspergillosis in patients with decompensated cirrhosis: case series
Discharge Outcomes of Hospitalized Patients with New Onset Decompensated Cirrhosis
Dynamic evolution of the sofosbuvir-associated variant A1343V in HEV-infected patients under concomitant sofosbuvir-ribavirin treatment